← FDA Drug Approvals (Drugs@FDA)

PROCHLORPERAZINE EDISYLATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: HIKMA · Approved 2022-11-22

Drug application

FDA Application #

ANDA213630

Application type

Abbreviated New Drug Application (Generic)

Brand name

PROCHLORPERAZINE EDISYLATE

Generic name

Prochlorperazine Edisylate

Active ingredients

PROCHLORPERAZINE EDISYLATE

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Discontinued

Sponsor

HIKMA

First approval

2022-11-22

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown